Cell Source, Inc. (CLCS) Operating income 2017–2024
Cell Source, Inc. (CLCS) annual operating income history from SEC filings — each fiscal year as reported.
-$3.8MFY2024 · since FY2017: -$2.3M → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$3.8M | +11.2% |
| FY2023 | -$4.3M | -3.6% |
| FY2022 | -$4.2M | -3.9% |
| FY2021 | -$4.0M | -10.5% |
| FY2020 | -$3.6M | +4.4% |
| FY2019 | -$3.8M | -89.7% |
| FY2018 | -$2.0M | +12.5% |
| FY2017 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLCS financial trends
CLCS RevenueCLCS Net incomeCLCS Net marginCLCS Gross profitCLCS Gross marginCLCS Operating marginCLCS Operating cash flowCLCS Free cash flowCLCS Capital expendituresCLCS Return on equityCLCS Stock buybacksCLCS Dividends paidCLCS Total assetsCLCS Total liabilitiesCLCS Shareholders’ equityCLCS overview →